Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results for the Second Quarter of Fiscal 2013  
11/15/2012 7:46:52 AM

NORTHVALE, N.J., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release product formulations and the manufacturing of generic pharmaceuticals, announced results for the fiscal second quarter ended September 30, 2012.